Clinical studies recruiting near Rehoboth Beach

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Beebe Health Campus · NRG Oncology · NCT05624996 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Beebe Health Campus · Alliance for Clinical Trials in Oncology · NCT06876714 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Beebe Health Campus · National Cancer Institute (NCI) · NCT04269902 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Beebe Health Campus · Canadian Cancer Trials Group · NCT06592924 Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely
Phase 3 · Beebe Health Campus · NRG Oncology · NCT03180268 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Beebe Health Campus · NRG Oncology · NCT04852887 mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg
Phase 3 · Beebe Health Campus · Alliance for Clinical Trials in Oncology · NCT05677490 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · Beebe Health Campus · National Cancer Institute (NCI) · NCT06058377 Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head
Phase 2 · Beebe Health Campus · ECOG-ACRIN Cancer Research Group · NCT02734537 S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · Beebe Health Campus · SWOG Cancer Research Network · NCT03418961 Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Diffe
Phase 3 · Beebe Health Campus · National Cancer Institute (NCI) · NCT06422806 Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Phase 2/Phase 3 · Beebe Health Campus · SWOG Cancer Research Network · NCT03851445 Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance C
Phase 3 · Beebe Health Campus · National Cancer Institute (NCI) · NCT07061977 A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NA · Beebe Health Campus · NRG Oncology · NCT04251052 Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippo
Phase 3 · Beebe Health Campus · NRG Oncology · NCT04804644 Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Can
Phase 3 · Beebe Health Campus · Alliance for Clinical Trials in Oncology · NCT05673148 Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Phase N/A · Beebe Health Campus · SWOG Cancer Research Network · NCT04871542 Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small
Phase 2/Phase 3 · Beebe Health Campus · National Cancer Institute (NCI) · NCT04402788 Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal
Phase 3 · Beebe Health Campus · NRG Oncology · NCT05879926 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemothera
Phase 3 · Beebe Health Campus · NRG Oncology · NCT07097142 Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Know
Phase 3 · Beebe Health Campus · Alliance for Clinical Trials in Oncology · NCT06661720 Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Phase 3 · Beebe Health Campus · SWOG Cancer Research Network · NCT05929768 Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Phase 2/Phase 3 · Beebe Health Campus · National Cancer Institute (NCI) · NCT06203600

Look up another city

Look up another condition